Invacare Holdings Quick Ratio (IVC) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Invacare Holdings Corporation  (IVC)

Invacare Holdings's Quick Ratio

IVC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Invacare Holdings's Cash & cash equivalent grew by 12.74 % in the Q1 2023 sequentially, while Current Liabilities decreased, this led to improvement in Invacare Holdings's Quick Ratio to 0.35, above Invacare Holdings Corporation average Quick Ratio.

Within Medical Equipment & Supplies industry 181 other companies have achieved higher Quick Ratio than Invacare Holdings in first quarter 2023. While Quick Ratio total ranking has improved so far during the Q1 2023 to 2948, from total ranking in the fourth quarter 2022 at 3667.

Explain Quick Ratio?
How much Cash & cash equivalents IVC´s has?
What are IVC´s Current Liabilities?




IVC Quick Ratio (Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
Y / Y Current Liabilities Change -16.57 % -11.01 % -2.77 % -6.4 % 6.27 %
Y / Y Cash & cash equivalent Change 26.65 % -29.8 % -38.31 % -43.89 % -39.18 %
Quick Ratio MRQ 0.35 0.28 0.21 0.2 0.23
IVC's Total Ranking # 2948 # 3667 # 3524 # 3584 # 3212
Seq. Current Liabilities Change -11.71 % -1.38 % -1.99 % -2.24 % -5.83 %
Seq. Cash & cash equivalent Change 12.74 % 29.39 % 3.48 % -16.1 % -37.5 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 182
Healthcare Sector # 929
Overall Market # 2948


Quick Ratio Statistics
High Average Low
0.81 0.34 0.08
(Dec 31 2017)   (Mar 31 2015)




Financial Statements
Invacare Holdings's Current Liabilities $ 189 Millions Visit IVC's Balance sheet
Invacare Holdings's Cash & cash equivalent $ 66 Millions Visit IVC's Balance sheet
Source of IVC's Sales Visit IVC's Sales by Geography


Cumulative Invacare Holdings's Quick Ratio

IVC's Quick Ratio for the trailling 12 Months

IVC Quick Ratio

(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -9.21 % -3.77 % 16.31 % 16.9 % 13.98 %
Y / Y Cash & cash equivalent TTM Growth -25.54 % -37.68 % -34.33 % -28.84 % -24.68 %
Quick Ratio TTM 0.26 0.23 0.25 0.28 0.31
Total Ranking TTM # 4625 # 4618 # 4623 # 4620 # 2821
Seq. Current Liabilities TTM Growth -4.27 % -2.92 % -0.68 % -1.63 % 1.46 %
Seq. Cash & cash equivalent TTM Growth 6.96 % -11.07 % -11.12 % -11.93 % -10.48 %


On the trailing twelve months basis IVC Cash & cash equivalent grew by 26.65 % in Q1 2023 year on year, while Current Liabilities fell to $189 millions, this led to increase in in Invacare Holdings's Quick Ratio to 0.26, Quick Ratio remained below IVC average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 251 other companies have achieved higher Quick Ratio than Invacare Holdings. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2022 from 4618 to 4625.

Explain Quick Ratio?
How much Cash & cash equivalents IVC´s has?
What are IVC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 252
Healthcare Sector # 1189
Within the Market # 4625


trailing twelve months Quick Ratio Statistics
High Average Low
0.77 0.37 0.09
(Mar 31 2018)   (Sep. 30, 2014)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Medical Equipment & Supplies Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Inspiremd Inc   0.96 $ 4.228  Millions$ 4.383  Millions
Glucotrack Inc   0.96 $ 1.003  Millions$ 1.047  Millions
Heartsciences Inc   0.92 $ 1.660  Millions$ 1.803  Millions
Adm Tronics Unlimited Inc   0.90 $ 1.004  Millions$ 1.114  Millions
Vivos Therapeutics Inc   0.88 $ 7.046  Millions$ 7.975  Millions
Neuropace Inc   0.88 $ 7.420  Millions$ 8.409  Millions
Bellevue Life Sciences Acquisition Corp  0.86 $ 0.349  Millions$ 0.403  Millions
Iridex Corp  0.84 $ 11.048  Millions$ 13.162  Millions
Monogram technologies inc   0.83 $ 7.719  Millions$ 9.321  Millions
Lensar Inc   0.80 $ 7.970  Millions$ 9.992  Millions
Zynex inc   0.80 $ 16.792  Millions$ 21.059  Millions
Atrion Corporation  0.76 $ 13.013  Millions$ 17.171  Millions
Medtronic Plc  0.73 $ 7,959.000  Millions$ 10,893.000  Millions
Artivion Inc   0.70 $ 30.773  Millions$ 43.961  Millions
Vaso Corporation  0.70 $ 18.253  Millions$ 26.223  Millions
Sanara Medtech Inc   0.69 $ 7.286  Millions$ 10.602  Millions
National Vision Holdings Inc   0.68 $ 246.906  Millions$ 361.763  Millions
Avanos Medical Inc   0.65 $ 95.700  Millions$ 146.400  Millions
Intelligent Bio Solutions Inc   0.64 $ 2.281  Millions$ 3.536  Millions
U S Physical Therapy Inc  0.64 $ 32.605  Millions$ 51.230  Millions
Smiledirectclub Inc   0.62 $ 59.125  Millions$ 95.406  Millions
Retractable Technologies Inc  0.62 $ 6.362  Millions$ 10.288  Millions
Regenicin Inc   0.60 $ 10.880  Millions$ 18.070  Millions
Avinger Inc   0.59 $ 10.370  Millions$ 17.641  Millions
Align Technology inc   0.58 $ 884.027  Millions$ 1,526.279  Millions
Nemaura Medical Inc   0.58 $ 10.105  Millions$ 17.523  Millions
T2 Biosystems Inc   0.57 $ 10.117  Millions$ 17.829  Millions
Dih Holding Us Inc   0.53 $ 3.175  Millions$ 5.956  Millions
Resmed Inc   0.52 $ 227.894  Millions$ 440.177  Millions
Envista Holdings Corporation  0.51 $ 585.200  Millions$ 1,149.600  Millions

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.